SUTTER ROSEVILLE MEDICAL CENTER — History
CCN 050309 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$1.1B
Latest Revenue (FY2022)
+14.7%
Revenue CAGR (3yr)
12.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $813M | $990M | $1.1B | +8.0% | +14.7% |
| Operating Expenses | $765M | $849M | $941M | +10.7% | +10.9% |
| Operating Margin | 5.9% | 14.2% | 12.1% | -15.1% | +43.0% |
| Net Income | $48M | $141M | $129M | -8.3% | +64.1% |
| Licensed Beds | 288 | 318 | 318 | +0.0% | +5.1% |
| Total Patient Days | 83,952 | 100,893 | 108,047 | +7.1% | +13.4% |
| Medicare Day % | 37% | 34% | 34% | +1.2% | -3.2% |
| Medicaid Day % | 8% | 7% | 6% | -9.8% | -13.0% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +31.6% ($813M → $1.1B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+14.7%
This Hospital
+7.6%
State Avg
Latest Margin
12.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.2B | 15.2% |
| FY2024 (proj) | $1.3B | 18.3% |
| FY2025 (proj) | $1.5B | 21.4% |